Antitumor Effect of Gemcitabine on Orthotopically Inoculated Human Gallbladder Cancer Cells in Nude Mice

被引:0
作者
Yoshiyasu Mita
Tetsuo Ajiki
Takashi Kamigaki
Taro Okazaki
Hiroshige Hori
Hideki Horiuchi
Kenro Hirata
Tsunenori Fujita
Takahiro Fujimori
Yoshikazu Kuroda
机构
[1] Kobe University Graduate School of Medical Sciences,Department of Gastroenterological Surgery
[2] Dokkyo University School of Medicine,Department of Surgical and Molecular Pathology
[3] Kobe University Graduate School of Medical Sciences,Department of Gastroenterological Surgery
来源
Annals of Surgical Oncology | 2007年 / 14卷
关键词
Gallbladder cancer; Gemcitabine; Survival; Apoptosis; PCNA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1374 / 1380
页数:6
相关论文
共 97 条
[1]  
Diehl AK(1980)Epidemiology of gallbladder cancer: a synthesis of recent data J Natl Cancer Inst 65 1209-14
[2]  
Gallardo JO(2001)A phase II study of gemcitabine in gallbladder carcinoma Ann Oncol 12 1403-6
[3]  
Rubio B(2004)Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer Invest New Drugs 22 193-8
[4]  
Fodor M(2004)A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma Am J Clin Oncol 27 565-9
[5]  
Orlandi L(2005)Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma Ann Oncol 16 279-81
[6]  
Yanez M(2005)Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree Cancer 104 1237-45
[7]  
Gamargo C(2005)Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study Jpn J Clin Oncol 35 68-73
[8]  
Ahumada M(2005)Treatment cost of pancreatic cancer in Japan: analysis of the difference after the introduction of gemcitabine Jpn J Clin Oncol 35 526-30
[9]  
Tsavaris N(2005)A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer Jpn J Clin Oncol 35 181-7
[10]  
Kosmas C(2006)Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Cancer Chemother Pharmacol 57 647-53